**Core tip:**The relationship between autophagy and perineural invasion (PNI) was explored for the first time in pancreatic cancer. Pancreatic cancer PNI is related to microtubule-associated protein 1A/1B-light chain 3 (LC3) expression-determined autophagy. PNI and LC3 expression were independent prognostic factors in pancreatic cancer. There might be a special association between autophagy and PNI, which contributes to pancreatic cancer progression. This study might provide a new insight for the mechanism of PNI in pancreatic cancer.

INTRODUCTION
============

Pancreatic cancer, also known as "the king of cancer", is a malignant tumor with a poor prognosis that has almost equal mortality and morbidity in patients. The incidence of pancreatic cancer is increasing yearly\[[@B1]\]. Surgical resection is the only possible cure of pancreatic cancer, although less than 20% of patients are eligible for radical surgery\[[@B2]\]. At the time of diagnosis, most pancreatic cancer patients have distant metastasis due to early occult symptoms, a lack of effective screening, and perineural growth characteristics. The incidence of perineural invasion (PNI) in pancreatic cancer is up to 80%-100% and is an important factor leading to postoperative pancreatic cancer recurrence. Previous studies have shown a higher recurrence rate after surgery and shorter disease-free and overall survival rates in cases of pancreatic cancer with PNI compared with those of cases without PNI. PNI evaluation of pancreatic cancer can predict disease recurrence and prognosis after surgery\[[@B3],[@B4]\]. However, the pathogenesis of PNI has not yet been defined.

Autophagy has a dual role in promoting and inhibiting tumor growth\[[@B5],[@B6]\]. Autophagy, as a mechanism of avoidance of anoikis in pancreatic cancer, is closely related to the survival of pancreatic cancer cells. Microtubule-associated protein 1A/1B-light chain 3 (LC3) is a typical marker of autophagy. LC3 labeling has been used to evaluate autophagy, and high levels of LC3 expression have been found in pancreatic cancer cells\[[@B7]\]. In addition, a previous study also showed that pancreatic cancer cells with PNI have higher levels of autophagy\[[@B7]\].

No study has examined the relationship between autophagy and PNI in pancreatic cancer cells. However, it can be inferred that only those pancreatic cancer cells that can survive within nerve tissues can eventually develop into a clinically visible form of pancreatic cancer PNI. Autophagy is likely one of the mechanisms involved in cancer cell survival. Therefore, this study focused on the relationship between pancreatic cancer cell autophagy and PNI, clinicopathological features, and prognosis, with an aim to provide a clinical basis for further study of the autophagy mechanisms affecting the pathogenesis of pancreatic cancer PNI.

MATERIALS AND METHODS
=====================

General data
------------

Retrospective data were collected from 109 cases of pathologically confirmed pancreatic ductal adenocarcinoma patients who underwent radical surgery for pancreatic cancer from January 2011 to August 2016 at the First Affiliated Hospital of Zhengzhou University. The included pancreatic cancer patients were not treated with radiation or chemotherapy prior to surgery, but received postoperative adjuvant gemcitabine- or non-gemcitabine-based chemotherapy, and/or radiotherapy. Tissue specimens were fixed in formalin and paraffin-embedded for histological study. Clinical and pathological data were collected, and all cases were followed. The date of surgical resection was considered as the starting time, and August 2016 was the deadline. The primary endpoint was death due to pancreatic cancer. Eighty cases were followed for more than 12 mo. All patients provided informed consent for the collection of biological samples, and this study was approved by the Institutional Review Board of the First Affiliated Hospital of Zhengzhou University (Scientific Research No. 5, 2015).

Out of the 109 patients studied, 61 were male, and 48 were female. Their ages ranged from 19 to 81 years, and the median age was 59 years. Tumor diameters ranged from 0.7-12 cm with a median value of 4.0 cm. The survival time of 80 patients who were followed for more than 12 mo was 1 to 54 mo, and the median survival time was 20 mo. By the end of the follow-up period, 38 patients had died. The clinical stages were classified according to the AJCC 2011 standard.

Immunohistochemistry
--------------------

Expression levels of LC3 and the nerve fiber marker ubiquitin carboxy-terminal hydrolase (UCH) were detected by immunohistochemistry using a standardized streptavidin-peroxidase (SP) method and the SP immunohistochemical Kit (ZSGB-Bio, Beijing, China) according to the manufacturer's instructions. The pancreatic cancer tissues were routinely embedded in paraffin and sliced into 4-μm-thick continuous sections. The sections were then warmed in an autoclave to remove residual wax and were hydrated before antigen retrieval. Endogenous peroxidase activity was eliminated by incubating the tissue sections at room temperature with 3% H~2~O~2~ for 10 min. The tissue sections were washed three times with PBS continuously and incubated with a small amount of goat serum at room temperature in a closed chamber for 15 min. The goat serum was then poured off (not washed), and anti-LC3 (Proteintech Group, diluted 1:120) and anti-UCH antibodies (Proteintech, diluted 1:100) were added and incubated overnight at 4 °C. The next day, the slides were thoroughly washed with PBS, and a biotinylated secondary antibody in a working liquid was added and incubated at room temperature for 15 min. After the slides were washed carefully with PBS again, horseradish peroxidase was added, and the slides were incubated for 5 min at room temperature. The slides were then rinsed with PBS three times, and a drop of DAB buffer was placed on the tissue slice and rinsed after 1 min to stop the color reaction. Then, the nuclei were stained with hematoxylin, and the samples were dehydrated in gradient alcohol, covered with transparent balata, and observed by microscopy. PBS was used in place of the primary antibody to serve as the negative control, and a known positive slice served as the positive control. The immunohistochemical results were evaluated in a double-blind manner by two pathologists. If the results were inconsistent, a third pathologist reviewed the data to reach a consensus.

LC 3 immunohistochemical score
------------------------------

LC3-positive cells detected by immunohistochemistry required the following characteristics: (1) clear cell structure; (2) accurate localization of the positive particle; and (3) obviously higher pigmentation than that of the background and clear contrast. Positive LC3 expression was mainly localized in pancreatic cancer cell cytoplasm. Five random power fields (400 × magnification) were observed for each case using an optical microscope. One hundred homogeneous cells were counted, and the staining intensity and the proportion of positive cells were observed. A semi-quantitative analysis was conducted using the product method. Dye intensity was scored as follows: no yellow, 0 points; light yellow, 1 point; yellow or deep yellow, 2 points; and brown or tan, 3 points. The expression range was scored as follows: \<10%, 0 points; 10% to 25%, 1 point; 26% to 50%, 2 points; 51% to 75%, 3 points; and \>75%, 4 points. The value from dye intensity was then multiplied by the value from the expression range to obtain the overall score: 0 points, negative (-); 1 to 3 points, weakly positive (+); 4 to 6 points, moderately positive (+ +); and 7 to 12 points, strongly positive (+ + +). More than 3 points indicated high expression, and 3 points or fewer indicated low expression.

PNI evaluation
--------------

UCH was expressed in the cytoplasm of all nerve fibers. The location of nerve fibers can be clearly defined by UCH to determine the invasion of cancer cells to the nerve tissue. According to previous reports, positive PNI status was determined as cancer cells being found in the perineural spaces, perineurium or nerve tract\[[@B8]\].

Survival analysis
-----------------

The effects of clinicopathological factors such as LC3 expression and PNI on the overall survival in pancreatic cancer were analyzed in 80 patients with more than 12 mo of follow-up data. The following factors were included in the survival analysis: LC3 expression, age, gender, tumor location, tumor size, histological grade, clinical stage, vascular invasion, lymph node metastasis, pancreatitis, diabetes status, and preoperative CA19-9 level.

Data analysis
-------------

Statistical analyses were performed using SPSS 19.0 and GraphPad Prism 5.0 statistical software. Enumeration data were checked by the Chi-square test or the four-grid table Fisher exact probability method. Correlations between clinicopathological factors such as LC3 expression and PNI were analyzed using the Spearman correlation method. LC3 expression and the factors that independently influenced neural infiltration were analyzed using two categories and unconditional logistic regression. Univariate and multivariate analyses were performed on factors that might affect the prognosis according to a COX risk regression model. The survival curve was plotted according to the Kaplan-Meier method. Results were considered significant when *P* \< 0.05.

RESULTS
=======

Evaluation of LC3 expression and PNI in pancreatic cancer
---------------------------------------------------------

LC3 expression was mainly localized to the cytoplasm. In contrast to normal paraneoplastic pancreatic tissues (Figure [1A](#F1){ref-type="fig"}), the expression of LC3 in pancreatic cancer tissues ranged from low to high in four grades: negative, weakly positive, moderately positive, and strongly positive (Figure [1B](#F1){ref-type="fig"}-E). The immunohistochemical results indicated that LC3 protein expression was observed in pancreatic ducts, acinar epithelial cells, islet cells, and pancreatic cancer tissues. There was significantly increased LC3 protein expression in pancreatic cancer tissues and peritumoral tissues. In 109 pancreatic cancer tissues, 42 had low LC3 expression (termed "low autophagy level"), including 6 (5.5%) negative cases and 36 (33%) weakly positive cases (Figure [1B](#F1){ref-type="fig"} and C); while 67 had high LC3 expression (termed "high autophagy level"), including 50 (45.9%) that were moderately positive and 17 (15.6%) that were strongly positive (Figure [1D](#F1){ref-type="fig"} and E). PNI by pancreatic cancer cells occurred mainly in the pancreatic cancer stroma. According to a previous study\[[@B9]\], four types of relationships exist between PNI and cancer nests: no PNI, perineurium invasion, perineural space invasion, and invasion to the nerve fiber tracts. In 109 cases of pancreatic cancer, 75 were positive (Figure [1F](#F1){ref-type="fig"}-I), and 34 were negative for nerve invasion. The positive rate of nerve invasion was 68.8%. High LC3 expression was also found in the nests surrounding the PNI (Figure [1I](#F1){ref-type="fig"}).

![Representative immunohistochemical results of microtubule-associated protein 1A/1B-light chain 3 and perineural invasion. A: Negative expression of LC3 in normal paraneoplastic pancreatic tissue (× 200); B: Negative expression of LC3 in pancreatic cancer tissue (× 200); C: Weakly positive expression of LC3 in pancreatic cancer tissue (× 200); D: Moderately positive expression of LC3 in pancreatic cancer tissue (× 200); E: Strongly positive expression of LC3 in pancreatic cancer tissue (× 200); F and G: Perineural invasion in pancreatic cancer tissues (× 400, arrow represents cancer cells infiltrating into nerve tissue); H: Pancreatic cancer cells with high LC3 expression enclosing and invading into nerve tissue (× 200, arrow represents cancer cells infiltrating into nerve tissue); I: Pancreatic cancer cells with high LC3 expression enclosing and invading into nerve tissue (× 400, arrow represents cancer cells infiltrating into nerve tissue). LC3: Microtubule-associated protein 1A/1B-light chain 3.](WJG-23-7232-g001){#F1}

Relationship between LC3 expression and PNI in pancreatic cancer
----------------------------------------------------------------

The analysis of LC3 expression and PNI of pancreatic cancer demonstrated a significant positive correlation between these two parameters (*P* = 0.018, *r* = 0.227). LC3 expression in pancreatic cancer tissues with PNI was significantly higher than that in pancreatic cancer tissues without PNI (Table [1](#T1){ref-type="table"}).

###### 

Relationship between microtubule-associated protein 1A/1B-light chain 3 expression and perineural invasion in pancreatic cancer

  **LC3**           **PNI**   ***P* value**   ***r***   
  ----------------- --------- --------------- --------- -------
  Low expression    18        22              0.018     0.227
  High expression   16        53                        

***P* \< 0.05, PNI absent *vs* present. PNI: Perineural invasion**

Relationship between pancreatic cancer cell autophagy and PNI and clinicopathological features
----------------------------------------------------------------------------------------------

LC3 expression was associated with lymph node metastasis (*P* \< 0.05). LC3 expression was not related to sex, gender, tumor location, tumor size, histological grade, clinical stage, vascular invasion, or diabetes mellitus status. PNI was related to lymph node metastasis, pancreatitis, and CA19-9 levels (*P* \< 0.05) and was not related to sex, age, tumor location, tumor size, histological grade, clinical stage, vascular invasion, or diabetes mellitus status (Table [2](#T2){ref-type="table"}).

###### 

Relationships of perineural invasion and microtubule-associated protein 1A/1B-light chain 3 expression with clinicopathological features

  ----------------------- ------------- -------------------- --------------------- --------------------------------------- --------------- ---- ---------------------------------------
  **Parameter**           ***n***       **PNI**              ***P* value**         **LC3**                                 ***P* value**        
  **Absent**              **Present**   **Low expression**   **High expression**                                                                
  Age (yr)                                                                                                                                      
  ≤ 58                    54            19                   35                    0.373                                   23              31   0.206
  \> 58                   55            15                   40                    17                                      38                   
  Gender                                                                                                                                        
  Male                    61            15                   46                    0.093                                   26              35   0.148
  Female                  48            19                   29                    14                                      34                   
  Tumor location                                                                                                                                
  Head                    66            17                   49                    0.129                                   28              38   0.124
  Body/tail               43            17                   26                    12                                      31                   
  Tumor size (cm)                                                                                                                               
  ≤ 2                     18            6                    12                    0.83                                    8               10   0.455
  \> 2                    91            28                   63                    32                                      59                   
  Histologic grade                                                                                                                              
  Well or moderate        74            24                   50                    0.685                                   23              51   0.077
  Poor                    35            10                   25                    17                                      18                   
  Vascular invasion                                                                                                                             
  Negative                83            26                   57                    0.957                                   31              52   0.801
  Positive                26            8                    18                    9                                       17                   
  Lymph node metastasis                                                                                                                         
  Negative                36            17                   19                    0.011[a](#T2FN1){ref-type="table-fn"}   18              18   0.043[a](#T2FN1){ref-type="table-fn"}
  Positive                73            17                   56                    22                                      51                   
  AJCC stage                                                                                                                                    
  I + II                  69            22                   47                    0.838                                   25              44   0.895
  III + IV                40            12                   28                    15                                      25                   
  Pancreatitis                                                                                                                                  
  Negative                30            15                   15                    0.009[a](#T2FN1){ref-type="table-fn"}   12              18   0.659
  Positive                79            19                   60                    28                                      51                   
  Diabetes                                                                                                                                      
  Negative                89            27                   62                    0.684                                   33              56   0.862
  Positive                20            7                    13                    7                                       13                   
  CA19-9 level (U/mL)                                                                                                                           
  ≤ 37                    37            19                   19                    0.001[a](#T2FN1){ref-type="table-fn"}   13              24   0.808
  \> 37                   72            15                   57                    27                                      45                   
  ----------------------- ------------- -------------------- --------------------- --------------------------------------- --------------- ---- ---------------------------------------

*P* \< 0.05, LC3 low expression *vs* high expression; PNI absent *vs* present. LC3: Microtubule-associated protein 1A/1B-light chain 3; PNI: Perineural invasion.

Multivariate logistic regression analysis of LC3 expression and PNI
-------------------------------------------------------------------

The clinicopathological factors possibly associated with LC3 expression and PNI were evaluated by multivariate analysis using a logistic regression model. The clinicopathological factors included LC3 expression and nerve infiltration, age, tumor site, tumor size, histological grade, clinical stage, vascular invasion, lymph node metastasis, diabetes, pancreatitis, and preoperative CA19-9 level. The results showed that LC3 expression, lymph node metastasis, pancreatitis, and CA19-9 level were the factors that influenced the occurrence of PNI, which was an independent factor affecting LC3 expression (Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}).

###### 

Multivariate logistic regression analysis of perineural invasion with clinicopathological features in pancreatic cancer

  ------------------------------------------------ ----------------- -------------------- -------------------- --------------------------------------- ---------------- --------------
  **Parameter**                                    **Estimate, B**   **Standard error**   **Wald statistic**   ***P* value**                           **Odds ratio**   **95%CI**
  Lymph node metastasis (positive *vs* negative)   1.068             0.499                4.581                0.032[a](#T3FN1){ref-type="table-fn"}   2.911            1.094-7.743
  CA199 (\> 37 U/mL *vs* ≤ 37 U/mL)                1.508             0.493                9.368                0.002[a](#T3FN1){ref-type="table-fn"}   4.520            1.720-11.874
  Pancreatitis (present *vs* absent)               1.301             0.514                6.419                0.011[a](#T3FN1){ref-type="table-fn"}   3.673            1.343-10.049
  LC3 (high *vs* low)                              1.032             0.491                4.406                0.036[a](#T3FN1){ref-type="table-fn"}   2.806            1.071-7.351
  Constant                                         -7.209            1.799                16.058               0                                       0.001            
  ------------------------------------------------ ----------------- -------------------- -------------------- --------------------------------------- ---------------- --------------

*P* \< 0.05. CI: Confidence interval; LC3: Microtubule-associated protein 1A/1B-light chain 3; PNI: Perineural invasion.

###### 

Multivariate logistic regression analysis of microtubule-associated protein 1A/1B-light chain 3 expression with clinicopathological features in pancreatic cancer

  **Parameter**               **Estimate, B**   **Standard error**   **Wald statistic**   ***P* value**                          **Odds ratio**   **95%CI**
  --------------------------- ----------------- -------------------- -------------------- -------------------------------------- ---------------- -------------
  PNI (present *vs* absent)   0.997             0.427                5.451                0.02[a](#T4FN1){ref-type="table-fn"}   2.71             1.174-6.259
  Constant                    -1.115            0.732                2.316                0.128                                  0.328            

*P* \< 0.05. PNI: Perineural invasion.

Survival analysis
-----------------

According to LC3 expression, patients were divided into a high-expression or a low-expression group. The overall survival rate of the low-expression group was better than that of the high-expression group, and the risk of death was 2.78-times higher in the LC3 high-expression group than that in the low-expression group. This difference between the two groups was significant (Figure [2A](#F2){ref-type="fig"}). The patients were also divided into a nerve-invasion group and a no-nerve-invasion group according to whether there was nerve infiltration. The overall survival rate of the patients without nerve invasion was better than that of the nerve-invasion group. The risk of death was 2.93-times greater in the PNI-positive group than in the PNI-negative group, and the difference between the two groups was significant (Figure [2B](#F2){ref-type="fig"}). Univariate analysis showed that CA19-9 level, PNI, and LC3 expression influenced the prognosis (Table [5](#T5){ref-type="table"}). A factor of *P* \< 0.2 was added into the COX risk regression model. Multivariate analysis was performed using the stepwise conditional method. The results showed that PNI and LC3 expression were independent prognostic factors that influenced pancreatic cancer (Table [6](#T6){ref-type="table"}).

![Kaplan-Meier estimates of overall survival in patients who underwent radical surgery. A: The overall survival rate of the LC3 low-expression group was better than that of the high-expression group (*P* \< 0.05); B: The overall survival rate of the patients without nerve invasion group was better than that of those with nerve infiltration (*P* \< 0.05).](WJG-23-7232-g002){#F2}

###### 

Univariate analysis of survival in patients who underwent radical surgery

  **Parameter**                                     **Hazard ratio**   **95%CI**     ***P* value**
  ------------------------------------------------- ------------------ ------------- ---------------------------------------
  PNI (present *vs* absent)                         3.701              1.539-8.903   0.003[a](#T5FN1){ref-type="table-fn"}
  LC3 (high *vs* low)                               3.196              1.433-7.126   0.005[a](#T5FN1){ref-type="table-fn"}
  Sex (male *vs* female)                            1.154              0.590-2.260   0.676
  Age (\> 58 yr *vs* ≤ 58 yr)                       1.176              0.621-2.225   0.619
  Tumor location (body/tail *vs* head)              1.102              0.570-2.131   0.773
  Histologic grade (poorly *vs* well or moderate)   1.287              0.636-2.604   0.484
  Tumor size (\> 2 cm *vs* ≤ 2 cm)                  0.940              0.444-1.991   0.871
  Vascular invasion (positive *vs* negative)        1.821              0.883-3.755   0.105
  Lymph node metastasis (positive *vs* negative)    0.871              0.449-1.688   0.682
  AJCC stage (III + IV *vs* I + II)                 1.473              0.752-2.889   0.259
  Diabetes (present *vs* absent)                    1.105              0.522-2.337   0.795
  Pancreatitis (present *vs* absent)                1.075              0.520-2.222   0.845
  CA19-9 level (\> 37 U/mL *vs* ≤ 37 U/mL)          2.648              1.286-5.454   0.008[a](#T5FN1){ref-type="table-fn"}

*P* \< 0.05. LC3: Microtubule-associated protein 1A/1B-light chain 3; PNI: Perineural invasion.

###### 

Multivariable analysis of survival in patients who underwent radical surgery

  **Parameter**               **Hazard ratio**   **95%CI**     ***P* value**
  --------------------------- ------------------ ------------- ---------------------------------------
  PNI (present *vs* absent)   2.962              1.212-7.238   0.017[a](#T6FN1){ref-type="table-fn"}
  LC3 (high *vs* low)         2.491              1.107-5.608   0.027[a](#T6FN1){ref-type="table-fn"}

*P* \< 0.05. LC3: Microtubule-associated protein 1A/1B-light chain 3; PNI: Perineural invasion.

DISCUSSION
==========

Pancreatic cancer has a poor treatment outcome because of a low resection rate, early invasion and metastasis, and insensitivity to radiotherapy and chemotherapy\[[@B10]-[@B13]\]. PNI is common in pancreatic cancer, and also found in breast, prostate, and rectal cancers\[[@B14]\]. Many studies have suggested that PNI is the main cause of abdominal pain in patients and is also one of the important causes of local recurrence of pancreatic cancer\[[@B15]-[@B19]\]. PNI is a continuous process involving multiple molecular factors and tumor microenvironment, but it is unclarified how cancer cells maintain their survival and proliferation from pancreatic cancer tissues to the external pancreatic plexus\[[@B20]\]. Autophagy is the process of degrading cytoplasmic proteins or organelles through lysosomes. Under physiological conditions, autophagy plays a major role in maintaining the intracellular environment stability\[[@B21],[@B22]\]. Autophagy is an important mechanism of escaping apoptosis for tumor cells. Moreover, autophagy may mediate resistance to chemotherapy in pancreatic cancer\[[@B23]-[@B25]\]. Therefore, this study was designed and completed in a retrospective manner to evaluate the relationship between pancreatic cancer cell autophagy and PNI and patient survival.

This study found that high expression of LC3 was present in the cancer nests around the nerve infiltration, consistent with the discovery of Yang et al\[[@B7]\]. In histology terms, it has been suggested that high LC3 expression is related to PNI. Further analysis of immunohistochemical data showed that there was a significant positive correlation between LC3 expression and PNI in pancreatic cancer tissues. Therefore, we speculated that, in the PNI process, a high autophagy level may assist cancer cells in escaping apoptosis, avoiding the damage of adverse stress and providing energy for the invasion and metastasis of pancreatic cancer.

There is dissidence in the correlation between PNI and lymph node metastasis\[[@B26]-[@B28]\]. This study showed that PNI was associated with lymph node metastasis, pancreatitis, and CA19-9 levels (*P* \< 0.05), while it had no association with sex, age, tumor location, tumor size, histological grade, clinical stage, vascular invasion, or diabetes mellitus. LC3 was related to lymph node metastasis but no other clinicopathological features. Multivariate logistic regression analysis also showed that LC3, lymph node metastasis, pancreatitis, and CA19-9 levels were the factors that influenced PNI, while PNI was an independent factor affecting LC3 expression. Tanaka et al\[[@B26]\] and Ozaki et al\[[@B28]\] believe that lymph node metastasis can promote PNI. The cancer cells in lymph node metastases can form a lymphatic satellite around the nerve and break through the nerve membrane; then, nerve invasion occurs. This study is consistent with results suggesting the need for regional lymph node dissection during surgical treatment\[[@B27]\]. Through this study, we can conclude that high LC3 expression, lymph node metastasis, pancreatitis, and CA19-9 levels usually indicate the possibility of nerve invasion. Gender, age, tumor site, tumor size, histological grade, clinical stage, vascular invasion, and diabetes are not effective indicators of neural invasion and autophagy and cannot be used as a determinant of resection of the peripancreatic nerve during surgery.

The overall survival rates of the LC3 high-expression group and the nerve-invasion group were significantly lower than those of the low-expression group and the no-nerve-invasion group. Univariate analysis showed that the level of CA19-9, PNI, and autophagy were associated with prognostic factors. Multivariate analysis showed that PNI and high LC3 expression were independent prognostic factors in pancreatic cancer patients. Autophagy is very complex and often plays an important role in tumor progression\[[@B6],[@B29]\]. Interestingly, this study found that high autophagy level is closely related to PNI, while both of which are independent risk factors for pancreatic cancer with a poor prognosis. The autophagy associated with poor survival in pancreatic cancer could be explained by the properties of autophagy assisting cancer cells to evade stress-induced apoptosis in PNI environment and undoubtedly promote tumor cell survival\[[@B30],[@B31]\]. Therefore, the high autophagy of cancer cells may promote the malignant progression of pancreatic cancer, resulting in PNI and the poor treatment outcome in patients with the disease.

In summary, autophagy and PNI of pancreatic cancer cells are independent risk factors for adverse prognosis. There is a significant correlation between them, and there may be a pathway between them through which they interact with each other to promote the malignant progression of pancreatic cancer. How to control the role of autophagy in PNI of pancreatic cancer and then improve cancer prognosis requires further studies into the molecular mechanisms involved.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

Pancreatic cancer is a malignant tumor with a poor prognosis that has almost equal mortality and morbidity in patients. At the time of diagnosis, most pancreatic cancer patients have distant metastasis due to early occult symptoms, a lack of effective screening, and perineural growth characteristics. The incidence of perineural invasion (PNI) in pancreatic cancer is 80%-100% and is an important factor leading to postoperative pancreatic cancer recurrence. PNI evaluation of pancreatic cancer can predict disease recurrence and prognosis after surgery. However, the pathogenesis of PNI has not yet been defined. Autophagy, as a mechanism of avoidance of anoikis in pancreatic cancer, is closely related to the survival of pancreatic cancer cells. Microtubule-associated protein 1A/1B-light chain 3 (LC3) is a typical marker of autophagy. LC3 labeling has been used to evaluate autophagy, and high levels of LC3 expression have been found in pancreatic cancer cells. In addition, a previous study showed that pancreatic cancer cells with PNI have higher levels of autophagy. No study has examined the relationship between autophagy and PNI in pancreatic cancer cells.

Research motivation
-------------------

The relationship between autophagy and PNI was explored for the first time in pancreatic cancer. Pancreatic cancer PNI is related to LC3 expression-determined autophagy. PNI and LC3 expression were independent prognostic factors in pancreatic cancer. There might be a special association between autophagy and PNI, which contributes to pancreatic cancer progression. This study might provide new insight into the mechanism of PNI in pancreatic cancer.

Research objectives
-------------------

This study focused on the relationship between pancreatic cancer cell autophagy and PNI, clinicopathological features, and prognosis. The authors found that autophagy and PNI of pancreatic cancer cells are independent risk factors for adverse prognosis. There is a significant correlation between them, and there may be a pathway between them through which they interact with each other to promote the malignant progression of pancreatic cancer. Controlling the role of autophagy in PNI of pancreatic cancer may improve cancer prognosis, which requires further studies into the molecular mechanisms involved.

Research methods
----------------

Clinical and pathological data were retrospectively collected from 109 patients with pancreatic ductal adenocarcinoma who underwent radical resection at the First Affiliated Hospital of Zhengzhou University from January 2011 to August 2016. Expression levels of the autophagy-related protein LC3 and perineural invasion marker ubiquitin carboxy-terminal hydrolase in pancreatic cancer tissues were detected by immunohistochemistry. The correlations among LC3 expression, perineural invasion, and clinical pathological features in pancreatic cancer were analyzed. The patients were followed for further survival analysis.

Research results
----------------

In this study, they found that LC3, lymph node metastasis, pancreatitis, and CA199 level were factors that influenced neural invasion, whereas only neural invasion itself was an independent factor of high LC3 expression. Perineural invasion and LC3 expression were independent risk factors for poor prognosis in pancreatic cancer. There is a significant correlation between them.

Research conclusions
--------------------

This study focused on the relationship between pancreatic cancer cell autophagy and PNI, clinicopathological features and prognosis. The authors found that autophagy and PNI of pancreatic cancer cells are independent risk factors for adverse prognosis. There is a significant correlation between them, and there must be a pathway between them through which they interact with each other to promote the malignant progression of pancreatic cancer. Controlling the role of autophagy in PNI of pancreatic cancer may improve cancer prognosis, which requires further studies into the molecular mechanisms involved.
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